ETFs Nipro Corporation

8086

JP3673600007

Medical Equipment, Supplies & Distribution

Market Closed - Japan Exchange Other stock markets 02:30:00 2026-06-22 EDT			5-day change	1st Jan Change
1,624.50 ^JPY	-1.37%		-2.02%	+9.99%

05-12	Nipro Corporation Provides Consolidated Earnings Guidance for the Six Months Ending September 30, 2026 and Fiscal Year Ending March 31, 2027	CI
05-12	Nipro Corporation Announces Year-End Dividend for Fiscal Year Ended March 31, 2026, Payable on June 10, 2026; Provides Second Quarter-End and Year-End Dividend Guidance for Fiscal Year Ending March 31, 2027	CI

ETFs positioned on Nipro Corporation

Name		YTD change	Weight	AuM
VANGUARD INTERNATIONAL EQUITY INDEX FUNDS - VANGUARD FTSE ALL-WORLD EX-US ETF		+9.10%	0%	33,076 M€

Nipro Corp is a Japan-based company mainly engaged in the medical, pharmaceutical, and pharma packaging businesses. It has three segments. The Medical segment consists of the domestic business division and the international business division. The domestic business division sells medical devices related to injections and infusions, artificial organs, high-performance medicines, and dialysis. The international business division, centered on the head office, has medical device manufacturing and sales bases overseas for regional expansion, selling medical devices related to injections and infusions, artificial organs, and diabetes. The Pharmaceutical segment sells pharmaceuticals related to kit preparation containers on a contract basis from pharmaceutical companies. The Pharma Packaging segment sells medical glass products such as glass tubes and ampoules, thermos flasks, and kit preparation containers in Japan.

Employees

39,168

Sector

Medical Equipment, Supplies & Distribution

Calendar

08-09 - Earnings release - Q1 2027

More about the company